医療用受託研究アウトソーシングの世界市場2021-2028:産業分析、規模、シェア、成長、動向、予測

• 英文タイトル:Healthcare Contract Research Outsourcing Market (Service: Clinical Trial Service, Regulatory Services, Clinical Data Management & Biometrics, Medical Writing, Pharmacovigilance, Site Management Protocol, and Others; Therapeutic Area: Oncology/Hematology, CNS, CV/Metabolic, Respiratory, Infectious Diseases, Immunology, Rare Diseases, Medical Devices, and Others; and End-user: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Academic Institutes & Government Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Healthcare Contract Research Outsourcing Market (Service: Clinical Trial Service, Regulatory Services, Clinical Data Management & Biometrics, Medical Writing, Pharmacovigilance, Site Management Protocol, and Others; Therapeutic Area: Oncology/Hematology, CNS, CV/Metabolic, Respiratory, Infectious Diseases, Immunology, Rare Diseases, Medical Devices, and Others; and End-user: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Academic Institutes & Government Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028「医療用受託研究アウトソーシングの世界市場2021-2028:産業分析、規模、シェア、成長、動向、予測」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2205A111
• 出版社/出版日:Transparency Market Research / 2022年4月30日
• レポート形態:英文、PDF、200ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥782,325 (USD5,795)▷ お問い合わせ
  Multi User¥1,187,325 (USD8,795)▷ お問い合わせ
  Corporate License¥1,592,325 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本調査資料では、世界の医療用受託研究アウトソーシング市場について調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、サービス別(臨床試験サービス、規制サービス、臨床データ管理・生体認証、メディカルライター、ファーマコビジランス)分析、エンドユーザー別分析、治療別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などの項目を掲載しています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界の医療用受託研究アウトソーシング市場規模:サービス別(臨床試験サービス、規制サービス、臨床データ管理・生体認証、メディカルライター、ファーマコビジランス)
・世界の医療用受託研究アウトソーシング市場規模:エンドユーザー別
・世界の医療用受託研究アウトソーシング市場規模:治療別
・世界の医療用受託研究アウトソーシング市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

Healthcare Contract Research Outsourcing Market – Scope of Report
TMR’s report on the global healthcare contract research outsourcing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global healthcare contract research outsourcing market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global healthcare contract research outsourcing market from 2021 to 2028.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the healthcare contract research outsourcing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global healthcare contract research outsourcing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global healthcare contract research outsourcing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global healthcare contract research outsourcing market.

The report delves into the competitive landscape of the global healthcare contract research outsourcing market. Key players operating in the global healthcare contract research outsourcing market have been identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global healthcare contract research outsourcing market profiled in this report.

Key Questions Answered in Healthcare Contract Research Outsourcing Market Report
What will be the sales/revenue generated by healthcare contract research outsourcing across all the geographies during the forecast period?
What are the key trends in the healthcare contract research outsourcing market?
What are the major drivers, restraints, and opportunities in the market?
Which region is set to grow at the highest CAGR during the forecast period?
Which segment will have the highest revenue globally in 2028 and which services segment will grow at the highest CAGR during the forecast period?

Healthcare Contract Research Outsourcing Market – Research Objectives and Research Approach
The comprehensive report on the global healthcare contract research outsourcing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global healthcare contract research outsourcing market in terms of service, therapeutic area, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2028 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global healthcare contract research outsourcing market.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Healthcare Contract Research Outsourcing Market
4. Market Overview
4.1. Introduction
4.1.1. Service Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. Regulatory Scenario by Region/globally
5.3. COVID-19 Impact Analysis
6. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by Service
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Service, 2017–2028
6.3.1. Clinical Trial Services
6.3.2. Regulatory Services
6.3.3. Clinical Data Management & Biometrics
6.3.4. Medical Writing
6.3.5. Pharmacovigilance
6.3.6. Site Management Protocol
6.3.7. Others
6.4. Market Attractiveness Analysis, by Service
7. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value & Volume Forecast, by End-user, 2017–2028
7.3.1. Pharmaceutical Companies
7.3.2. Biotechnology Companies
7.3.3. Medical Devices
7.3.4. Academic Institutes & Government Organizations
7.4. Market Attractiveness Analysis, by End-user
8. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by Therapeutic Area
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028
8.3.1. Oncology/Hematology
8.3.2. CNS
8.3.3. CV/Metabolic
8.3.4. Respiratory
8.3.5. Infectious Diseases
8.3.6. Immunology
8.3.7. Rare Diseases
8.3.8. Medical Devices
8.3.9. Others
8.4. Market Attractiveness Analysis, by Therapeutic Area
9. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value & Volume Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Healthcare Contract Research Outsourcing Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Service, 2017–2028
10.2.1. Clinical Trial Services
10.2.2. Regulatory Services
10.2.3. Clinical Data Management & Biometrics
10.2.4. Medical Writing
10.2.5. Pharmacovigilance
10.2.6. Site Management Protocol
10.2.7. Others
10.3. Market Value & Volume Forecast, by End-user, 2017–2028
10.3.1. Pharmaceutical Companies
10.3.2. Biotechnology Companies
10.3.3. Medical Devices
10.3.4. Academic Institutes & Government Organizations
10.4. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028
10.4.1. Oncology/Hematology
10.4.2. CNS
10.4.3. CV/Metabolic
10.4.4. Respiratory
10.4.5. Infectious Diseases
10.4.6. Immunology
10.4.7. Rare Diseases
10.4.8. Medical Devices
10.4.9. Others
10.5. Market Value & Volume Forecast, by Country, 2017–2028
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Service
10.6.2. By End-user
10.6.3. By Therapeutic Area
10.6.4. By Country
11. Europe Healthcare Contract Research Outsourcing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Service, 2017–2028
11.2.1. Clinical Trial Services
11.2.2. Regulatory Services
11.2.3. Clinical Data Management & Biometrics
11.2.4. Medical Writing
11.2.5. Pharmacovigilance
11.2.6. Site Management Protocol
11.2.7. Others
11.3. Market Value & Volume Forecast, by End-user, 2017–2028
11.3.1. Pharmaceutical Companies
11.3.2. Biotechnology Companies
11.3.3. Medical Devices
11.3.4. Academic Institutes & Government Organizations
11.4. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028
11.4.1. Oncology/Hematology
11.4.2. CNS
11.4.3. CV/Metabolic
11.4.4. Respiratory
11.4.5. Infectious Diseases
11.4.6. Immunology
11.4.7. Rare Diseases
11.4.8. Medical Devices
11.4.9. Others
11.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Service
11.6.2. By End-user
11.6.3. By Therapeutic Area
11.6.4. By Country/Sub-region
12. Asia Pacific Healthcare Contract Research Outsourcing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Service, 2017–2028
12.2.1. Clinical Trial Services
12.2.2. Regulatory Services
12.2.3. Clinical Data Management & Biometrics
12.2.4. Medical Writing
12.2.5. Pharmacovigilance
12.2.6. Site Management Protocol
12.2.7. Others
12.3. Market Value & Volume Forecast, by End-user, 2017–2028
12.3.1. Pharmaceutical Companies
12.3.2. Biotechnology Companies
12.3.3. Medical Devices
12.3.4. Academic Institutes & Government Organizations
12.4. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028
12.4.1. Oncology/Hematology
12.4.2. CNS
12.4.3. CV/Metabolic
12.4.4. Respiratory
12.4.5. Infectious Diseases
12.4.6. Immunology
12.4.7. Rare Diseases
12.4.8. Medical Devices
12.4.9. Others
12.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Service
12.6.2. By End-user
12.6.3. By Therapeutic Area
12.6.4. By Country/Sub-region
13. Latin America Healthcare Contract Research Outsourcing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Service, 2017–2028
13.2.1. Clinical Trial Services
13.2.2. Regulatory Services
13.2.3. Clinical Data Management & Biometrics
13.2.4. Medical Writing
13.2.5. Pharmacovigilance
13.2.6. Site Management Protocol
13.2.7. Others
13.3. Market Value & Volume Forecast, by End-user, 2017–2028
13.3.1. Pharmaceutical Companies
13.3.2. Biotechnology Companies
13.3.3. Medical Devices
13.3.4. Academic Institutes & Government Organizations
13.4. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028
13.4.1. Oncology/Hematology
13.4.2. CNS
13.4.3. CV/Metabolic
13.4.4. Respiratory
13.4.5. Infectious Diseases
13.4.6. Immunology
13.4.7. Rare Diseases
13.4.8. Medical Devices
13.4.9. Others
13.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Service
13.6.2. By End-user
13.6.3. By Therapeutic Area
13.6.4. By Country/Sub-region
14. Middle East & Africa Healthcare Contract Research Outsourcing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value & Volume Forecast, by Service, 2017–2028
14.2.1. Clinical Trial Services
14.2.2. Regulatory Services
14.2.3. Clinical Data Management & Biometrics
14.2.4. Medical Writing
14.2.5. Pharmacovigilance
14.2.6. Site Management Protocol
14.2.7. Others
14.3. Market Value & Volume Forecast, by End-user, 2017–2028
14.3.1. Pharmaceutical Companies
14.3.2. Biotechnology Companies
14.3.3. Medical Devices
14.3.4. Academic Institutes & Government Organizations
14.4. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028
14.4.1. Oncology/Hematology
14.4.2. CNS
14.4.3. CV/Metabolic
14.4.4. Respiratory
14.4.5. Infectious Diseases
14.4.6. Immunology
14.4.7. Rare Diseases
14.4.8. Medical Devices
14.4.9. Others
14.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Service
14.6.2. By End-user
14.6.3. By Therapeutic Area
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Company Profiles
15.3.1. Syneos Health
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. PAREXEL International
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. ICON plc
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. PRA Health Sciences, Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. Charles River
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Strategic Overview
15.3.6. Laboratory Corporation of America Holdings (Covance)
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. IQVIA
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. Medpace
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. Pharmaceutical Product Development, LLC.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview




• 英文レポート名:Healthcare Contract Research Outsourcing Market (Service: Clinical Trial Service, Regulatory Services, Clinical Data Management & Biometrics, Medical Writing, Pharmacovigilance, Site Management Protocol, and Others; Therapeutic Area: Oncology/Hematology, CNS, CV/Metabolic, Respiratory, Infectious Diseases, Immunology, Rare Diseases, Medical Devices, and Others; and End-user: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Academic Institutes & Government Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
• 日本語訳:医療用受託研究アウトソーシングの世界市場2021-2028:産業分析、規模、シェア、成長、動向、予測
• レポートコード:MRC2205A111お問い合わせ(見積依頼・ご注文・質問)